COVID-19

Pic:getty/tosheo

EU nears decision on Novavax COVID-19 vaccine

By Rachel Arthur

The European Medicines Agency (EMA) could issue an opinion on Novavax’ Conditional Marketing Authorization for its COVID-19 vaccine ‘within weeks’.

© GettyImages/VectorFusionArt

Special Edition: BioPharma Hubs

Dublin set to get a life sciences incubation and acceleration cluster

By Jane Byrne

A new specialized lab, office and collaboration space for over 100 life science and health technology professionals, entrepreneurs, and researchers was recently announced for The Campus, Cherrywood in South Dublin, Ireland.

© GettyImages/peepo

EU and AstraZeneca reach settlement over vaccine delivery

By Jane Byrne

The European Commission and AstraZeneca have settled their dispute over the supply of COVID-19 vaccine, Vaxzevria, in a move that will see the EU receive 200 million doses of the drug maker’s shot by March 2022.

Pic:getty/richarddrury

mRNA and beyond: Opportunities for US biologics

By Staff reporter

The success of mRNA vaccine technology could be one of the new opportunities for US pharmaceutical manufacturing looking forward, with pandemic investments helping turbocharge the sector.

Follow us

Products

View more

Webinars